Pfizer moves forward with weight loss pill

Pfizer plans to move a reworked, once-daily version of its danuglipron weight-loss pill into clinical trials later this year, after scrapping a twice-daily version of the drug late last year.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO